Tuberculosis & HIV: Treatment

DO. SEE. HEAR. KNOW. Visit TheBody.com's 2008 World AIDS Day Center >>

BROWSE TOPICS IN HIV TREATMENT:

HIV Treatment: Home Page

Just Diagnosed

HIV Medications

First Steps to Treatment

HIV Drug Resistance

Switching or Stopping Treatment

Third Line/Rescue Treatment

Hepatitis C Coinfection

Women & Pregnancy

HIV Treatment for Children

Side Effects & Health Problems

Research & Experimental Drugs

HIV Treatment in the Developing World

FDA Issues "Black Box" Warning for Cipro, Similar Drugs (July 9, 2008)
From Project Inform
Mycobacterium Tuberculosis: Treatment in the United States and Other High-Income Nations (2006)
A chapter from Clinical Manual for Management of the HIV-Infected Adult.
From AIDS Education & Training Centers National Resource Center
Tuberculosis Treatment in Resource-Limited Settings (2006)
A chapter from Clinical Manual for Management of the HIV-Infected Adult.
From AIDS Education & Training Centers National Resource Center
Virtual Medicine: Web-Based Record System Proves as Potent as Drugs in Treating Tuberculosis (August 9, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
The Tuberculosis Treatment Pipeline (July 2005)
To read PDF, click here
From Treatment Action Group
An Overview of Rifampin (Rifadin, Rimactane) (February 10, 2005)
To read PDF, click here
From U.S. National Institutes of Health
Drug Interaction Warning: Saquinavir/Ritonavir and Rifampin (Rifampicin, Rifadin, Rimactane, Rofact) (February 8, 2005)
To read PDF, click here
From U.S. Food and Drug Administration
Mycobacterium tuberculosis Disease (December 17, 2004)
A chapter from "Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents" guidelines.
To read PDF, click here
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
An Overview of Isoniazid (INH, Nydrazid) (October 6, 2004)
To read PDF, click here
From U.S. National Institutes of Health
Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors (January 20, 2004)
To read PDF, click here
From U.S. Centers for Disease Control and Prevention
Surgeon General: Treatment in Prison Can Prevent Disease Outside (January 13, 2004)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Tuberculosis Treatment Evolves (October 2003)
New guidelines reflect subtle but important shifts in strategy.
In GMHC Treatment Issues, from Gay Men's Health Crisis
Avoid Rifampin/Pyrazinamide Treatment in TB Patients, CDC Says (August 8, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Treatment of Tuberculosis (June 20, 2003)
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
Technology Transfer Will Allow Countries to Produce Own TB Drugs (June 5, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Scale Up the Global Fight Against Tuberculosis (March 28, 2003)
Excerpts from an op-ed column by Gro Harlem Brundtland, director-general of the World Health Organization, and James D. Wolfensohn, president of the World Bank.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Directly Observed Treatment Short Course for TB: A Treatment to Match a Killer Infection (March 27, 2003)
Excerpts from an editorial in the Akron Beacon Journal.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Controlling Tuberculosis in India (November 25, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Treatment of Tuberculosis (PDF) (October 2002)
Revised guidelines from the American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society of America.
New Drugs Sought for Top Killer of Young Women Worldwide (July 31, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
African Treatment Programs Often Overestimate Tuberculosis Drug Doses (May 17, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Notice to Readers: Acquired Rifamycin Resistance in Persons With Advanced HIV Disease Being Treated for Active Tuberculosis With Intermittent Rifamycin-Based Regimens (March 15, 2002)
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
Tuberculosis: Guidelines Changed for Latent TB Treatment (September 21, 2001)
To read PDF, click here
In AIDS Treatment News, from AIDS Treatment News
The Georgia TB Reference Guide (PDF) (September 2001)
From Atlanta Tuberculosis Prevention Coalition
Update: Fatal and Severe Liver Injuries Associated With Rifampin and Pyrazinamide for Latent Tuberculosis Infection, and Revisions in American Thoracic Society/CDC Recommendations -- United States, 2001 (PDF) (August 31, 2001)
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
Severe Liver Damage With TB Drugs (May 29, 2001)
From Canadian AIDS Treatment Information Exchange
An Inexpensive Antibiotic Proves Effective in Reducing Death Among People With HIV and TB in Africa (May 1999)
From U.S. Centers for Disease Control and Prevention
A New Treatment for TB (June 1998)
In AIDS Care, from San Francisco General Hospital
A Short Two-Drug Regimen Prevents Active TB (April 1998)
In GMHC Treatment Issues, from Gay Men's Health Crisis
New Two-Month TB Prophylaxis Regimen Is as Effective as Yearlong Therapy (April 1998)
In AIDS Care, from San Francisco General Hospital
Guidelines for the Administration of Protease Inhibitors and Rifampin in HIV-Positive Patients With Tuberculosis (October 1997)
In HIV Newsline, from San Francisco General Hospital
TB or Not TB: Do You Have Tuberculosis? (October 1997)
In AIDS Care, from San Francisco General Hospital
The Challenge of Multidrug-Resistant Tuberculosis (October 1997)
In HIV Newsline, from San Francisco General Hospital
Tuberculosis Therapy and the New Protease Inhibitors (November 1996)
In GMHC Treatment Issues, from Gay Men's Health Crisis
A History of TB Treatment (July 23, 1996)
From New Jersey Medical School
Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children (January 1, 1994)
In American Journal of Respiratory and Critical Care Medicine, from American Lung Association

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.